SLC22A1 and chronic myelogenous leukemia, BCR-ABL1 positive: In conclusion, the present exploratory study comprehensively screened for SLC22A1 genetic variations and investigated its linkage and haplotype pattern in three distinct Asian populations, followed by its association with IM pharmacokinetics in CML patients.